NCT00390520View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00390520 - Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter